-
Fund Dashboard
- Holdings
abrdn Healthcare Investors
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 67.17 mm | 727.22 k shares | 6.88 | Common equity | Long | USA |
AMGN Amgen Inc. | 55.97 mm | 214.75 k shares | 5.74 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 53.73 mm | 75.43 k shares | 5.51 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 47.31 mm | 117.48 k shares | 4.85 | Common equity | Long | USA |
AstraZeneca PLC
|
31.39 mm | 479.07 k shares | 3.22 | Common equity | Long | UK |
UNH UnitedHealth Group Incorporated | 27.90 mm | 55.16 k shares | 2.86 | Common equity | Long | USA |
BIIB Biogen Inc. | 27.47 mm | 179.64 k shares | 2.82 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 25.38 mm | 208.70 k shares | 2.60 | Common equity | Long | USA |
LLY Eli Lilly and Company | 24.58 mm | 31.84 k shares | 2.52 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 24.27 mm | 369.22 k shares | 2.49 | Common equity | Long | USA |
BNTX BioNTech SE | 24.09 mm | 211.40 k shares | 2.47 | Common equity | Long | Germany |
ALNY Alnylam Pharmaceuticals, Inc. | 23.41 mm | 99.50 k shares | 2.40 | Common equity | Long | USA |
Argenx SE
|
19.98 mm | 32.49 k shares | 2.05 | Common equity | Long | Netherlands |
ASND Ascendis Pharma A/S | 17.40 mm | 126.42 k shares | 1.78 | Common equity | Long | Denmark |
NEUROVANCE MILESTONE INTEREST
|
17.02 mm | 49.01 k shares | 1.74 | Common equity | Long | USA |
ILMN Illumina, Inc. | 16.57 mm | 124.03 k shares | 1.70 | Common equity | Long | USA |
ABBV AbbVie Inc. | 16.18 mm | 91.04 k shares | 1.66 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 15.75 mm | 30.17 k shares | 1.61 | Common equity | Long | USA |
ABT Abbott Laboratories | 15.64 mm | 138.26 k shares | 1.60 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 15.21 mm | 852.28 k shares | 1.56 | Common equity | Long | USA |
uniQure NV
|
14.35 mm | 812.69 k shares | 1.47 | Common equity | Long | Netherlands |
NBIX Neurocrine Biosciences, Inc. | 14.09 mm | 103.24 k shares | 1.44 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 14.04 mm | 26.99 k shares | 1.44 | Common equity | Long | USA |
State Street Institutional US Government Money Market Fund | 13.66 mm | 13.66 mm shares | 1.40 | Short-term investment vehicle | Long | USA |
MRK Merck & Co., Inc. | 12.69 mm | 127.56 k shares | 1.30 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 12.33 mm | 147.61 k shares | 1.26 | Common equity | Long | USA |
INSM Insmed Incorporated | 12.31 mm | 178.33 k shares | 1.26 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 12.20 mm | 149.01 k shares | 1.25 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 10.36 mm | 220.15 k shares | 1.06 | Common equity | Long | USA |
CURASEN THERAPEUTICS, INC. | 10.12 mm | 21.11 mm shares | 1.04 | Preferred equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 9.08 mm | 215.73 k shares | 0.93 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 8.79 mm | 354.98 k shares | 0.90 | Common equity | Long | USA |
ELV Elevance Health Inc. | 8.51 mm | 23.07 k shares | 0.87 | Common equity | Long | USA |
INSP Inspire Medical Systems, Inc. | 8.43 mm | 45.50 k shares | 0.86 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 8.12 mm | 232.14 k shares | 0.83 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 7.49 mm | 33.00 k shares | 0.77 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 6.84 mm | 120.99 k shares | 0.70 | Common equity | Long | USA |
JNJ Johnson & Johnson | 6.41 mm | 44.31 k shares | 0.66 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 6.37 mm | 162.40 k shares | 0.65 | Common equity | Long | Canada |
KRYS Krystal Biotech, Inc. | 6.03 mm | 38.46 k shares | 0.62 | Common equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 5.95 mm | 2.88 mm shares | 0.61 | Preferred equity | Long | USA |
GH Guardant Health, Inc. | 5.93 mm | 194.16 k shares | 0.61 | Common equity | Long | USA |
MRNA Moderna, Inc. | 5.63 mm | 135.35 k shares | 0.58 | Common equity | Long | USA |
Oculis Holding AG
|
5.56 mm | 327.11 k shares | 0.57 | Common equity | Long | Switzerland |
DHR Danaher Corporation | 5.46 mm | 23.78 k shares | 0.56 | Common equity | Long | USA |
Teva Pharmaceutical Industries Ltd
|
5.20 mm | 235.82 k shares | 0.53 | Common equity | Long | Israel |
BSX Boston Scientific Corporation | 5.17 mm | 57.88 k shares | 0.53 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 5.12 mm | 15.40 k shares | 0.52 | Common equity | Long | USA |
ENGRAIL THERAPEUTICS INC. SERI | 5.05 mm | 4.77 mm shares | 0.52 | Preferred equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 4.94 mm | 192.28 k shares | 0.51 | Common equity | Long | USA |
ZTS Zoetis Inc. | 4.84 mm | 29.73 k shares | 0.50 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 4.70 mm | 249.80 k shares | 0.48 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 4.67 mm | 267.83 k shares | 0.48 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 4.58 mm | 224.76 k shares | 0.47 | Common equity | Long | USA |
THC Tenet Healthcare Corporation | 4.54 mm | 35.98 k shares | 0.47 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals, Inc. | 4.52 mm | 1.20 mm shares | 0.46 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 4.48 mm | 321.39 k shares | 0.46 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 4.42 mm | 158.73 k shares | 0.45 | Common equity | Long | USA |
MOH Molina Healthcare, Inc. | 4.36 mm | 14.99 k shares | 0.45 | Common equity | Long | USA |
HCA HCA Healthcare, Inc. | 4.34 mm | 14.45 k shares | 0.44 | Common equity | Long | USA |
Alkermes PLC
|
4.32 mm | 150.05 k shares | 0.44 | Common equity | Long | Ireland |
TNDM Tandem Diabetes Care, Inc. | 4.30 mm | 119.45 k shares | 0.44 | Common equity | Long | USA |
ENDEAVOR BIOMEDICINES, INC. | 4.29 mm | 657.32 k shares | 0.44 | Preferred equity | Long | USA |
Medtronic PLC
|
4.18 mm | 52.38 k shares | 0.43 | Common equity | Long | Ireland |
SRRK Scholar Rock Holding Corporation | 4.00 mm | 92.59 k shares | 0.41 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 3.95 mm | 82.58 k shares | 0.40 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corporation | 3.78 mm | 630.85 k shares | 0.39 | Common equity | Long | USA |
GERN Geron Corporation | 3.65 mm | 1.03 mm shares | 0.37 | Common equity | Long | USA |
QLARIS BIO, INC. | 3.45 mm | 4.39 mm shares | 0.35 | Preferred equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 3.44 mm | 40.70 k shares | 0.35 | Common equity | Long | USA |
DXCM DexCom, Inc. | 3.44 mm | 44.20 k shares | 0.35 | Common equity | Long | USA |
ARBOR BIOTECHNOLOGIES | 3.40 mm | 827.25 k shares | 0.35 | Preferred equity | Long | USA |
Incendia Therapeutics, Inc. | 3.40 mm | 1.77 mm shares | 0.35 | Preferred equity | Long | USA |
QUELL THERAPEUTICS | 3.23 mm | 1.55 mm shares | 0.33 | Preferred equity | Long | USA |
ATALANTA THERAPEUTICS | 3.20 mm | 1.78 mm shares | 0.33 | Preferred equity | Long | USA |
GPCR Structure Therapeutics Inc. | 3.13 mm | 115.38 k shares | 0.32 | Common equity | Long | Cayman Islands |
RECODE THERAPEUTICS | 3.06 mm | 331.41 k shares | 0.31 | Preferred equity | Long | USA |
INVETX MILESTONE INTEREST | 3.02 mm | 31.19 k shares | 0.31 | Preferred equity | Long | USA |
ABCURO, INC. | 2.93 mm | 532.82 k shares | 0.30 | Preferred equity | Long | USA |
SEISMIC THERAPEUTICS, INC. | 2.92 mm | 647.72 k shares | 0.30 | Preferred equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 2.91 mm | 51.92 k shares | 0.30 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 2.72 mm | 101.99 k shares | 0.28 | Common equity | Long | USA |
Merus NV
|
2.36 mm | 56.17 k shares | 0.24 | Common equity | Long | Netherlands |
AVTR Avantor, Inc. | 2.31 mm | 109.66 k shares | 0.24 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 2.29 mm | 29.20 k shares | 0.23 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 2.21 mm | 41.34 k shares | 0.23 | Common equity | Long | USA |
PODD Insulet Corporation | 2.20 mm | 8.41 k shares | 0.23 | Common equity | Long | USA |
SYK Stryker Corporation | 2.15 mm | 5.97 k shares | 0.22 | Common equity | Long | USA |
THIRD ARC BIO, INC | 1.95 mm | 926.72 k shares | 0.20 | Preferred equity | Long | USA |
MCK McKesson Corporation | 1.94 mm | 3.40 k shares | 0.20 | Common equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 1.84 mm | 632.39 k shares | 0.19 | Preferred equity | Long | USA |
XNCR Xencor, Inc. | 1.80 mm | 78.14 k shares | 0.18 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 1.79 mm | 243.77 k shares | 0.18 | Common equity | Long | USA |
NUVIG THERAPEUTICS, INC | 1.72 mm | 1.64 mm shares | 0.18 | Preferred equity | Long | USA |
AMOLYT MILESTONE | 1.71 mm | 15.98 k shares | 0.18 | Preferred equity | Long | USA |
INCENDIA THERAPEUTICS, INC. | 1.57 mm | 1.57 mm principal | 0.16 | Debt | Long | USA |
GLYCOMINE, INC. | 1.56 mm | 2.60 mm shares | 0.16 | Preferred equity | Long | USA |
IDXX IDEXX Laboratories, Inc. | 1.54 mm | 3.73 k shares | 0.16 | Common equity | Long | USA |
TCRX TScan Therapeutics, Inc. | 1.48 mm | 485.85 k shares | 0.15 | Common equity | Long | USA |
ARBOR BIOTECHNOLOGIES | 1.36 mm | 82.08 k shares | 0.14 | Preferred equity | Long | USA |
GRAL GRAIL, Inc. | 1.33 mm | 74.74 k shares | 0.14 | Common equity | Long | USA |
ETNB 89bio, Inc. | 1.30 mm | 166.13 k shares | 0.13 | Common equity | Long | USA |
ARKUDA THERAPEUTICS, INC. | 1.21 mm | 1.04 mm shares | 0.12 | Preferred equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 1.20 mm | 160.46 k shares | 0.12 | Common equity | Long | USA |
FLAMINGO THERAPEUTICS INC | 1.19 mm | 243.46 k shares | 0.12 | Preferred equity | Long | France |
PYXS Pyxis Oncology, Inc. | 977.55 k | 626.64 k shares | 0.10 | Common equity | Long | USA |
HIBERCELL, INC. SERIES B | 850.90 k | 2.77 mm shares | 0.09 | Preferred equity | Long | USA |
MRNS Marinus Pharmaceuticals, Inc. | 819.99 k | 1.53 mm shares | 0.08 | Common equity | Long | USA |
CURASEN THERAPEUTICS, INC. | 798.27 k | 1.66 mm shares | 0.08 | Preferred equity | Long | USA |
ENDEAVOR BIOMEDICINES INC. | 791.94 k | 121.38 k shares | 0.08 | Preferred equity | Long | USA |
RLYB Rallybio Corporation | 724.87 k | 755.08 k shares | 0.07 | Common equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 720.87 k | 720.87 k principal | 0.07 | Debt | Long | USA |
BIOTHERYX, INC. SERIES E | 709.01 k | 1.30 mm shares | 0.07 | Preferred equity | Long | USA |
HIBERCELL,INC. SERIES C | 708.97 k | 1.53 mm shares | 0.07 | Preferred equity | Long | USA |
AVICEDA THERAPEUTICS | 498.79 k | 86.60 k shares | 0.05 | Preferred equity | Long | USA |
HIBERCELL, INC. | 439.00 k | 439.00 k principal | 0.04 | Debt | Long | USA |
NVAX Novavax, Inc. | 298.99 k | 37.19 k shares | 0.03 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 263.74 k | 3.43 k shares | 0.03 | Common equity | Long | USA |
CONTRA CHINOOK THERAPE | 207.47 k | 91.80 k shares | 0.02 | Equity derivative | N/A | USA |
STRO Sutro Biopharma, Inc. | 127.68 k | 69.39 k shares | 0.01 | Common equity | Long | USA |
Mural Oncology PLC
|
56.00 k | 17.39 k shares | 0.01 | Common equity | Long | Ireland |
IMAB I-Mab | 45.80 k | 53.89 k shares | 0.00 | Common equity | Long | Cayman Islands |
State Street Institutional U.S. Government Money Market Fund | 30.22 k | 30.22 k shares | 0.00 | Short-term investment vehicle | Long | USA |
GRTX Galera Therapeutics, Inc. | 13.58 k | 296.46 k shares | 0.00 | Common equity | Long | USA |
CONTRA FUSION PHARMACE | 10.48 k | 7.59 k shares | 0.00 | Equity derivative | N/A | Canada |
TETRAPHASE PHARMACEUTICALS INC | 574.94 | 28.75 k shares | 0.00 | Equity derivative | N/A | USA |
ARKUDA THERAPEUTICS,INC SER A. | 235.39 | 2.35 mm shares | 0.00 | Preferred equity | Long | USA |
IO LIGHT HOLDINIGS, INC. | 42.16 | 421.63 k shares | 0.00 | Preferred equity | Long | USA |
PRIOTHERA LIMITED | 35.91 | 346.67 k shares | 0.00 | Preferred equity | Long | Ireland |
Willow Laboratories Inc.
|
16.00 | 160.00 k shares | 0.00 | Common equity | Long | USA |
HIBERCELL INC. | 5.49 | 5.49 mm shares | 0.00 | Equity derivative | N/A | USA |
HIBERCELL, INC. SERIES C | 1.53 | 1.53 mm shares | 0.00 | Equity derivative | N/A | USA |
CONTRA SPECTRUM PHARMA | 0.08 | 79.79 k shares | 0.00 | Equity derivative | N/A | USA |
AFFERENT MILESTONE INTEREST
|
0.03 | 26.21 k shares | 0.00 | Common equity | Long | USA |
ETHISMOS RESEARCH, INC. MILEST | 0 | 1.18 k shares | 0.00 | Preferred equity | Long | USA |
AMPHIVENA MILESTONE INTEREST | 0 | 100.00 shares | 0.00 | Preferred equity | Long | USA |